KRM Ayurveda IPO
Market Sentiment
IPO Details
IPO Reservation
Market Lot Size
Financial Analysis
| Metric | 2023 | 2024 | 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 89.38 | 67.57 | 76.95 | 48.65 |
| Expense | 79.29 | 62.85 | 60.61 | 37.65 |
| Profit (PAT) | 7.60 | 3.41 | 12.10 | 8.14 |
| Total Assets | 39.48 | 43.91 | 66.79 | 78.12 |
| Company | EPS | P/E | Market Cap (Cr) |
|---|---|---|---|
| Jeena Sikho Lifecare Ltd. | 8.86 | 76.58 | 31 |
| Vaidya Sane Ayurved Laboratories Ltd | 3.07 | 93.20 | 5 |
Promoters: Mr. Puneet Dhawan and Mrs. Tanya Dhawan
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 1,55,20,800 | 92.16% |
| Promoter Holding Post Issue | 2,12,60,800 | 67.28% |
Strengths & Risks
- Heavily oversubscribed — 74.4x overall (final).
- Strong institutional (QIB) demand — 63.3x.
- Solid profit margin — 15.7%.
- Strong return on equity — 68%.
- Elevated leverage — debt/equity of 1.31.
Auto-generated from live GMP, subscription, valuation and financial data. Informational only — not investment advice. Always read the RHP before applying.
Company Information
KRM Ayurveda Ltd started its journey on 3 September 2019, with the work of manufacturing Ayurvedic products, herbal and botanical remedies, medicines, supplements, and possibly skin care / wellness-related items. The company has many hospitals and clinics across India, not only in India, but it also provides telemedicine services and sales abroad. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. The company has good services for the patient, including In-Patient & Out-Patient Care, Panchakarma Therapies, Specialized Clinics, Medicinal Sales, Diet & Lifestyle Counseling.
| Purpose | Amount (Cr) |
|---|---|
| Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | 13.67 |
| Purchase of CRM Software and Hardware Infrastructure | 1.42 |
| Human Resources | 5.44 |
| Repayment/Prepayment of loan | 12.50 |
| Working Capital Requirement | 18.00 |
| General Corporate Purpose | - |
Resources & Documents
KRM Ayurveda Ltd., A-16, G T Karnal road, North West Delhi, New Delhi, 110033
KRM Ayurveda has set a price band of Rs 129–Rs 135 per share for an issue size of Rs 77 crore in the ayurveda & healthcare sector. The stock listed with a 33.85% gain versus its issue price on January 29, 2026.
KRM Ayurveda Ltd started its journey on 3 September 2019, with the work of manufacturing Ayurvedic products, herbal and botanical remedies, medicines, supplements, and possibly skin care / wellness-related items. The company has many hospitals and clinics across India, not only in India, but it also provides telemedicine services and sales abroad. The company operates in the ayurveda & healthcare space.
The issue is promoted by Mr. Puneet Dhawan and Mrs. Tanya Dhawan with NEXGEN Financial Solutions Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards Capital Expenditure for Construction and Development of Telemedicine Operational Facilities (Rs 14 crore) and Purchase of CRM Software and Hardware Infrastructure (Rs 1 crore).
Grey market is quoting a premium of +Rs 45 (+33.3% over issue price), up Rs 10 from the previous session. Final subscription data records overall subscription at 74.43x, retail at 54.21x, QIB at 63.31x, NII at 136.10x.
On fundamentals, the company is posting revenue growth of 13.9%, a profit margin of 15.7%, return on equity of 67.9% in its most recent reported period. Listed peers in this segment include Jeena Sikho Lifecare Ltd. (P/E 76.58x, market cap Rs 31 crore) and Vaidya Sane Ayurved Laboratories Ltd (P/E 93.20x, market cap Rs 5 crore) — useful reference points when evaluating the issue's pricing relative to where the broader sector are trading.
Our data-driven engine currently flags this issue as a Subscribe call — the composite picture tilts favourable, though not without some caveats. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
KRM Ayurveda IPO GMP — What It Means
The latest grey market premium for KRM Ayurveda IPO is ₹45 (+33.3%). GMP is an unofficial, dealer-quoted figure that hints at expected listing-day demand — it is not a guaranteed listing price. For KRM Ayurveda it should be read alongside the subscription numbers and the company's fundamentals, since grey-market premiums can swing sharply during the bidding window.
See the full KRM Ayurveda GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
No comments yet. Be the first to share your opinion!